ArticleFrontiers in pharmacology2012

Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome based on observations in high-risk neuroblastoma.

Tony A Koehn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.